CPA CPA - Cocrystal Pharma CFO CoCEO
| COCP Stock | USD 1.88 0.10 5.05% |
Insider
CPA CPA is CFO CoCEO of Cocrystal Pharma
| Age | 55 |
| Address | 19805 North Creek Parkway, Bothell, WA, United States, 98011 |
| Phone | 877 262 7123 |
| Web | https://www.cocrystalpharma.com |
Cocrystal Pharma Management Efficiency
The company has return on total asset (ROA) of (0.4606) % which means that it has lost $0.4606 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6886) %, meaning that it created substantial loss on money invested by shareholders. Cocrystal Pharma's management efficiency ratios could be used to measure how well Cocrystal Pharma manages its routine affairs as well as how well it operates its assets and liabilities. As of 12/11/2024, Return On Tangible Assets is likely to drop to -0.6. In addition to that, Return On Capital Employed is likely to drop to -0.7. As of 12/11/2024, Non Current Liabilities Other is likely to grow to about 366.4 K, while Total Current Liabilities is likely to drop slightly above 2.7 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Dominic Cundari | DiaMedica Therapeutics | 73 | |
| Jonathan Wygant | Veracyte | 53 | |
| Laetitia BachelotFontaine | Valneva SE ADR | N/A | |
| Joe Lewcock | Denali Therapeutics | N/A | |
| Marc Stapley | Veracyte | 54 | |
| Edward Calamai | DiaMedica Therapeutics | N/A | |
| Alexander MD | Denali Therapeutics | 51 | |
| Joseph Mara | Vericel Corp Ord | 48 | |
| Annie McGuire | Veracyte | 44 | |
| Adam Mendelsohn | Vivani Medical | 42 | |
| Lisa MD | Vivani Medical | 60 | |
| Elizabeth Evans | Vaccinex | 51 | |
| Joel Rothman | Equillium | 55 | |
| MBA CFA | Vaccinex | 50 | |
| Maurice Zauderer | Vaccinex | 78 | |
| MB FRCSEd | Vericel Corp Ord | 62 | |
| Truc MBA | Vivani Medical | 71 | |
| Tracy Morris | Veracyte | N/A | |
| Marc TessierLavigne | Denali Therapeutics | 64 | |
| Jonathan Siegal | Vericel Corp Ord | N/A | |
| Gerald Strohmaier | Valneva SE ADR | N/A | |
Management Performance
| Return On Equity | -0.69 | ||||
| Return On Asset | -0.46 |
Cocrystal Pharma Leadership Team
Elected by the shareholders, the Cocrystal Pharma's board of directors comprises two types of representatives: Cocrystal Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cocrystal. The board's role is to monitor Cocrystal Pharma's management team and ensure that shareholders' interests are well served. Cocrystal Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cocrystal Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sam Lee, Co-Founder and Pres | ||
| Roger Kornberg, Independent CoFounder | ||
| CPA CPA, CFO CoCEO | ||
| Prof Kornberg, Independent CoFounder |
Cocrystal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cocrystal Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.69 | ||||
| Return On Asset | -0.46 | ||||
| Current Valuation | 8.19 M | ||||
| Shares Outstanding | 10.17 M | ||||
| Shares Owned By Insiders | 31.85 % | ||||
| Shares Owned By Institutions | 6.94 % | ||||
| Number Of Shares Shorted | 8.01 K | ||||
| Price To Earning | 193.33 X | ||||
| Price To Book | 1.52 X | ||||
| Price To Sales | 92.45 X |
Pair Trading with Cocrystal Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Cocrystal Stock
Moving against Cocrystal Stock
| 0.64 | AMGN | Amgen Inc | PairCorr |
| 0.63 | ABBV | AbbVie Inc | PairCorr |
| 0.6 | TTOO | T2 Biosystms | PairCorr |
| 0.58 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.57 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.
The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.